Psychiatric and eye disorders associated with use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs)
Ilaria Ammendolia·Fabrizio Calapai·Emanuela Esposito·Gioacchino Calapai·Mariaconcetta Currò·Paola Midiri·Bernardo Firenzuoli·Alberto Noto·Antonino Cancellieri·Luigi Cardia·Alessio Ardizzone·Cristina Mondello